A United States Market Entry Analysis for a New Medical Device

This report provides an analysis of the market opportunities for a medical device developed by io, a New Zealand based company. The device simulates a high altitude, low oxygen environment to encourage the body to develop more red blood cells. Potential medical benefits derived from anecdotal sources have encouraged the company to begin clinical trials to determine efficacy as a medical device. Before committing to a beachhead market, io is interested in understanding the business opportunities in seven different treatment areas. A balanced scorecard was used to weight the different opportunities, aligning them with io’s requirements. The results of the market analysis show that chemotherapy induced anemia would be a promising first market followed by the second tier opportunities of insomnia, asthma, obesity and sleep apnea. The lowest scoring treatment areas analyzed were headache and hypertension. This analysis is contingent on io’s efficacy data being equal for all treatment areas.